Xu and colleagues described for the first time the negative role of AMPK in the regulation of HH pathway in hepatocellular carcinoma, where AMPK directly interacts with GLI1 and modulates its expression [106]. The gene discussed is GLI1; the disease is hepatocellular carcinoma.